JAMA ophthalmology · 2023
Will the Long-Named Perfluorohexyloctane Produce Long-lasting Improvements in Patients With Meibomian Gland Disease?
СтатьяКомментарийНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eid Pétra, Bourredjem Abderrahmane, Anwer Atif, Creuzot-Garcher Catherine, Keane Pearse Andrew, Zhou Yukun, Wagner Siegfried, Meriaudeau Fabrice, Arnould Louis
Аннотация
PURPOSE: To compare automated and semiautomated methods for the measurement of retinal microvascular biomarkers: the automated retinal vascular morphology (AutoMorph) algorithm and the Singapore "I" Vessel Assessment (SIVA) software.
METHODS: Analysis of retinal fundus photographs centered on optic discs from the population-based Montrachet Study of adults aged 75 years and older. Comparison and agreement evaluation with intraclass correlation coefficients (ICCs) between SIVA and AutoMorph measures of the central retinal venular and arteriolar equivalent, arteriolar-venular ratio, and fractal dimension.
RESULTS: Overall, 1069 fundus photographs were included in this study. The mean age of the patients was 80.04 ± 3.94 years. After the image quality grading process with an optimal threshold, the lowest rejection rate was 51.17% for the AutoMorph analysis (n = 522). The measure of agreement between SIVA and AutoMorph retinal microvascular biomarkers showed a good correlation for vascular complexity (ICC, 0.77-0.47), a poor correlation for vascular calibers (ICC, 0.36-0.23), and no correlation for vascular tortuosity. Significant associations between retinal biomarkers and systemic variables (age, history of stroke, and systolic blood pressure) were consistent between SIVA and AutoMorph.
CONCLUSIONS: In this dataset, AutoMorph presented a substantial rejection rate. SIVA and AutoMorph provided well-correlated measurements of vascular complexity and caliber with consistent clinical associations. Further comparisons are needed before a transition is made from semiautomated to automated algorithms for the analysis of retinal microvascular biomarkers.
TRANSLATIONAL RELEVANCE: Open source software needs to be compared with former semiautomated software for retinal microvascular biomarkers assessment before transition in daily clinic and collaborative research.
METHODS: Analysis of retinal fundus photographs centered on optic discs from the population-based Montrachet Study of adults aged 75 years and older. Comparison and agreement evaluation with intraclass correlation coefficients (ICCs) between SIVA and AutoMorph measures of the central retinal venular and arteriolar equivalent, arteriolar-venular ratio, and fractal dimension.
RESULTS: Overall, 1069 fundus photographs were included in this study. The mean age of the patients was 80.04 ± 3.94 years. After the image quality grading process with an optimal threshold, the lowest rejection rate was 51.17% for the AutoMorph analysis (n = 522). The measure of agreement between SIVA and AutoMorph retinal microvascular biomarkers showed a good correlation for vascular complexity (ICC, 0.77-0.47), a poor correlation for vascular calibers (ICC, 0.36-0.23), and no correlation for vascular tortuosity. Significant associations between retinal biomarkers and systemic variables (age, history of stroke, and systolic blood pressure) were consistent between SIVA and AutoMorph.
CONCLUSIONS: In this dataset, AutoMorph presented a substantial rejection rate. SIVA and AutoMorph provided well-correlated measurements of vascular complexity and caliber with consistent clinical associations. Further comparisons are needed before a transition is made from semiautomated to automated algorithms for the analysis of retinal microvascular biomarkers.
TRANSLATIONAL RELEVANCE: Open source software needs to be compared with former semiautomated software for retinal microvascular biomarkers assessment before transition in daily clinic and collaborative research.